51 suppliers listed in China.
Leading global source for raw peptide materials and large-scale manufacturing. These hubs specialize in competitive wholesale pricing and high-capacity synthesis for international export. Chinese peptide manufacturing is concentrated in Zhejiang province (including Hangzhou, Ningbo), Jiangsu province (Nanjing), and Fujian province, hosting CDMOs and API manufacturers serving global pharmaceutical and research markets. WuXi AppTec, PharmaBlock Sciences, and numerous regional manufacturers provide significant SPPS and LPPS capacity. The BIOSECURE Act and related US legislation are driving a restructuring of China-to-US peptide supply chains, with Import Alert 66-40 specifically targeting 22 Chinese facilities across Zhejiang and Jiangsu for steroid contamination testing and falsified COA records. Buyer due diligence on Chinese suppliers should include independent third-party quality audits and verification of GMP certifications.
Directory listing last reviewed August 2026.
Chinese manufacturing is concentrated in Zhejiang, Jiangsu, and Fujian provinces, spanning large-scale API producers and full-service peptide CDMOs. Compare each supplier's synthesis scale, export record, and quality documentation, and review finished-dose capability separately from raw API capacity on the peptide API pages.
Ask for the legal manufacturing entity, facility address, current GMP certificates, and batch-specific COAs matched to the quoted lot. Use the directory's third-party tested listings as a starting point, and compare against US-based manufacturers when supply-chain diversification matters.